Kristina Michelle Holt

Title: Kristina Michelle Holt: Innovator in Vaccine Adjuvants

Introduction

Kristina Michelle Holt is a prominent inventor based in Annapolis, MD (US). She has made significant contributions to the field of immunotherapy through her innovative work on vaccine adjuvants. With a total of 2 patents, her inventions aim to enhance the immune response in patients receiving vaccines or cancer treatments.

Latest Patents

Holt's latest patents include the "Human lymphocyte vaccine adjuvant" and the "Human lymphocyte medium adjuvant." Both inventions relate to adjuvants derived from human lymphocytes. These adjuvants can be used in combination with traditional vaccines or cancer immunotherapy to improve the patient's immune response. The adjuvants are derived from the supernatant collected from cultured activated lymphocytes, showcasing her innovative approach to enhancing immunotherapeutic efficacy.

Career Highlights

Throughout her career, Kristina has worked with notable organizations such as Hasumi, LLC and the University System of Maryland. Her work in these institutions has allowed her to further develop her research and contribute to advancements in the field of immunology.

Collaborations

Some of her notable coworkers include Kenichiro Hasumi and Dean LeMar Mann. Their collaboration has likely played a role in the development of her innovative patents and research initiatives.

Conclusion

Kristina Michelle Holt's contributions to vaccine adjuvants represent a significant advancement in immunotherapy. Her work continues to influence the field and offers promising solutions for enhancing patient outcomes.